Steroid-induced diabetes: A clinical and molecular approach to understanding and treatment

Jessica L. Hwang, Roy E Weiss

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Since the advent of glucocorticoid therapy for autoimmune disease in the 1940s, their widespread application has led to the concurrent therapy-limiting discovery of many adverse metabolic side effects. Unanticipated hyperglycemia associated with the initiation of glucocorticoids often leads to preventable hospital admissions, prolonged hospital stays, increased risks for infection and reduced graft function in solid organ transplant recipients. Challenges in managing steroid-induced diabetes stem from wide fluctuations in post-prandial hyperglycemia and the lack of clearly defined treatment protocols. The mainstay of treatment is insulin therapy coincident with meals. This article aims to review the pathogenesis, risk factors, diagnosis and treatment principles unique to steroid-induced diabetes.

Original languageEnglish (US)
Pages (from-to)96-102
Number of pages7
JournalDiabetes/Metabolism Research and Reviews
Volume30
Issue number2
DOIs
StatePublished - Feb 2014
Externally publishedYes

Fingerprint

Steroids
Hyperglycemia
Glucocorticoids
Meals
Transplants
Therapeutics
Clinical Protocols
Autoimmune Diseases
Length of Stay
Insulin
Infection

Keywords

  • Glucocorticoids
  • Insulin resistance
  • New onset diabetes after transplant
  • Steroid-induced diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Steroid-induced diabetes : A clinical and molecular approach to understanding and treatment. / Hwang, Jessica L.; Weiss, Roy E.

In: Diabetes/Metabolism Research and Reviews, Vol. 30, No. 2, 02.2014, p. 96-102.

Research output: Contribution to journalArticle

@article{bc533755ea6945fd9612101abea569e1,
title = "Steroid-induced diabetes: A clinical and molecular approach to understanding and treatment",
abstract = "Since the advent of glucocorticoid therapy for autoimmune disease in the 1940s, their widespread application has led to the concurrent therapy-limiting discovery of many adverse metabolic side effects. Unanticipated hyperglycemia associated with the initiation of glucocorticoids often leads to preventable hospital admissions, prolonged hospital stays, increased risks for infection and reduced graft function in solid organ transplant recipients. Challenges in managing steroid-induced diabetes stem from wide fluctuations in post-prandial hyperglycemia and the lack of clearly defined treatment protocols. The mainstay of treatment is insulin therapy coincident with meals. This article aims to review the pathogenesis, risk factors, diagnosis and treatment principles unique to steroid-induced diabetes.",
keywords = "Glucocorticoids, Insulin resistance, New onset diabetes after transplant, Steroid-induced diabetes",
author = "Hwang, {Jessica L.} and Weiss, {Roy E}",
year = "2014",
month = "2",
doi = "10.1002/dmrr.2486",
language = "English (US)",
volume = "30",
pages = "96--102",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Steroid-induced diabetes

T2 - A clinical and molecular approach to understanding and treatment

AU - Hwang, Jessica L.

AU - Weiss, Roy E

PY - 2014/2

Y1 - 2014/2

N2 - Since the advent of glucocorticoid therapy for autoimmune disease in the 1940s, their widespread application has led to the concurrent therapy-limiting discovery of many adverse metabolic side effects. Unanticipated hyperglycemia associated with the initiation of glucocorticoids often leads to preventable hospital admissions, prolonged hospital stays, increased risks for infection and reduced graft function in solid organ transplant recipients. Challenges in managing steroid-induced diabetes stem from wide fluctuations in post-prandial hyperglycemia and the lack of clearly defined treatment protocols. The mainstay of treatment is insulin therapy coincident with meals. This article aims to review the pathogenesis, risk factors, diagnosis and treatment principles unique to steroid-induced diabetes.

AB - Since the advent of glucocorticoid therapy for autoimmune disease in the 1940s, their widespread application has led to the concurrent therapy-limiting discovery of many adverse metabolic side effects. Unanticipated hyperglycemia associated with the initiation of glucocorticoids often leads to preventable hospital admissions, prolonged hospital stays, increased risks for infection and reduced graft function in solid organ transplant recipients. Challenges in managing steroid-induced diabetes stem from wide fluctuations in post-prandial hyperglycemia and the lack of clearly defined treatment protocols. The mainstay of treatment is insulin therapy coincident with meals. This article aims to review the pathogenesis, risk factors, diagnosis and treatment principles unique to steroid-induced diabetes.

KW - Glucocorticoids

KW - Insulin resistance

KW - New onset diabetes after transplant

KW - Steroid-induced diabetes

UR - http://www.scopus.com/inward/record.url?scp=84893446310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893446310&partnerID=8YFLogxK

U2 - 10.1002/dmrr.2486

DO - 10.1002/dmrr.2486

M3 - Article

C2 - 24123849

AN - SCOPUS:84893446310

VL - 30

SP - 96

EP - 102

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 2

ER -